Autologous bone marrow transplantation with marrow purged by mafosfamide in seven patients with myelodysplastic syndromes in transformation (AML-MDS): A pilot study

Leukemia

Volumn 7, Issue 12, 1993, Pages 2030-2033

  Laporte, J P ^a   Isnard, F ^a   Lesage, S ^a   Fenaux, P ^b   Douay, L ^a   Lopez, M ^a   Stachowiak, J ^a   Najman, A ^a   Gorin, N C ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAFOSFAMIDE;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ANEMIA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLAST CELL; BONE MARROW PURGING; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HUMAN; KARYOTYPE; LEUKOCYTE; MALE; MYELODYSPLASTIC SYNDROME; PRELEUKEMIA; PRIORITY JOURNAL; RELAPSE; REMISSION; THROMBOCYTE; TOXICITY;

ADULT; ANTINEOPLASTIC AGENTS; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; CYCLOPHOSPHAMIDE; FEASIBILITY STUDIES; FEMALE; HUMAN; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGE; MYELODYSPLASTIC SYNDROMES; PILOT PROJECTS; REMISSION INDUCTION; TRANSPLANTATION, AUTOLOGOUS;

EID: 0027762630     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Armitage JO, Dick FR, Needleham, SW, Burns CP. Effect of chemotherapy for the myelodysplastic syndrome. Cancer Treat Rep 1981;65:601-605.
2. Tricot G, Boogaerts MA. The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromes. Br J Haematol 1986;63;477-483.
3. Fenaux P, Lai JL, Jouet JP, Poilet JP, Bauters, F. Aggressive chemotherapy in adult primary myelodysplastic syndromes. Blut 1988;57:297-302.
4. Gajewski J, Ho W, Nimer S, Hirji K, Gekelman L, Jacobs A, Champlin R. Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome. J Clin Oncol 1989;7:1637-1645.
5. De Witte T, Muus P, De Pauw B, Haanen C. Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukaemia. Cancer 1990;66:831-837.
6. Martial P, Ferrant A, Michaux JL, Sokal G. Intensive chemotherapy for acute non-lymphoblastic leukemia after primary myelodysplastic syndrome. Hematol Oncol 1988; 6:299-305.
7. Fenaux P, Morel P, Rose, C, Lai JL, Jouet JP, Bauters F. Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy. Br J Haematol 1991;77:497-501.
8. Champlin R, Gale RP. Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies. Semin Hematol 1987;24:55-67.
9. Appelbaum FR, Storb R, Ramberg HM et al. Treatment of preleukemic syndromes with marrow transplantation. Blood 1987;69:92-96.
10. Bélanger R, Gyger M, Perreault C, Bonny Y, St-Louis J. Bone marrow transplantation for myelodysplastic syndromes. Br J Haematol 1988;69:29-33.
11. Appelbaum FR, Barrai Storb R et al. Bone marrow transplantation for patients with myelodyplasia: pretreatment variables and outcome. Ann Intern Med 1990;112: 590-597.
12. De Witte T, Zwaan, F, Hermans, J et al. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG) Br J Haematol 1990;74:151-154.
13. Bennett JM, Catovsky D., Daniel MTM, Flandrin G, Galton DAG, Granick M, Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-199.
14. Laporte JP, Gorin NC, Lemonnier MP, Isnard F, Najman A. A new combination of two intercalating agents (mitoxantrone + daunomycin) in adult refractory acute leukemia: the DON protocol. Cancer Chemother Pharmacol 1988;22:344-347.
15. Douay L, Mary JY, Giarratana MC, Najman A, Gorin NC. Establishment of reliable experimental procedure for bone marrow purging with mafosfamide (ASTA 7557). Exp Haematol 1989;17:429-432.
16. Hervé P, Tamayo E, Peters A. Autologous stem cell grafting in acute myeloid leukemia: technical approach of marrow incubation in vitro with pharmacological agents (prerequisite for clinical applications) Br J Haematol 1983;53:683-684.
17. Gorin NC. Collection, manipulation and freezing of hemopoietic stem cells. Clin Hematol 1986;15:19-48.
18. Santos GW, Tutschka PJ, Brooxmeyer R et al. Marrow transplantation for acute leukemia after treatment with busulfan and cyclophamide. N Engl J Med 1983;309: 1347-1353.
19. Meloni G, De Fabritis P, Papa G, Amadori S, Pulsini A, Simone F, Mandelli F. Cryopreserved autologous bone marrow infusion following high dose chemotherapy in first relapse. Leuk Res 1985;9:407-412.
20. Biron P, Goldstone A, Colombat P et al. A new cytoreductive conditionning regimen before ABMT for lymphoma: the BEAM protocol. A phase II study in autologous marrow transplantation. In: Dicke KA, Spitzer G, Zander AR. eds. Autologous bone marrow transplantation. Houston: University of Texas, MD Anderson Hospital and Tumor Institute, 1987, pp. 593-600.
21. Gorin N, Labopin M, Meloni et al. Autologous bone marrow transplantation for acute myeloblastic leukemia in europe: further evidence of the role of marrow purging by mafosfamide. Leukemia 1991;5:896-904.
22. Tefferi A, Thibodeau SN, Sorberg LA. Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment lenght polymorphisms. Blood 1990;75: 1770-1773.
23. Abrahamson G, Boultwood J, Madden J, et al. Clonality of cell populations in refractory anaemia using combined approach of gene loss and X-linked restriction fragment length polymorphism-methylation analysis. Br J Haematol 1991;79:550-555.
24. Douay L, Laporte JP, Mary JY et al. Difference of kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (Asia Z 7557). Bone Marrow Transpl 1987;2:33-43.
25. Öberg G, Simonsson B, Smedmyr B et al. Is haematological reconstitution seen after ABMT in MDS patients? Bone Marrow Transpl 1989; 4 (Suppl. 2): 52.